PLX272280

GSE74550: A designed inhibitor of p53 aggregation rescues p53 tumor-suppression in ovarian carcinomas

• Organsim human
• Type RNASEQ
• Target gene
• Project ARCHS4

Half of all human cancers lose p53 function by missense mutations, with an unknown fraction of these containing p53 in a self-aggregated, amyloid-like state. Here we show that a cell-penetrating peptide, ReACp53, designed to inhibit p53 amyloid formation, rescues p53 function in cancer cell lines and in organoids derived from high-grade serous ovarian carcinomas (HGSOC), an aggressive cancer characterized by ubiquitous p53 mutations. Rescued p53 behaves similarly to its wild-type counterpart in regulating target genes, reducing cell proliferation and increasing cell death. Intraperitoneal administration decreases tumor proliferation and shrinks xenografts in vivo. Our data show the effectiveness of targeting a specific aggregation defect of p53 and its potential applicability to HGSOCs. SOURCE: Sanaz Memarzadeh (smemarzadeh@mednet.ucla.edu) - University of California, Los Angeles